Zecyte 500mg (Abiraterone)

Product Overview

Zecyte 500mg contains Abiraterone Acetate, a potent oral medicine used for the primary treatment of aggressive prostate cancer. It does this by reducing androgen production. This is vital for the development and longevity of prostate cancer tumor cells.

Prostate cancer cells depend upon androgens (male hormones, such as testosterone) for growth. By preventing androgen production, not just within the testes, but also within the adrenal glands, as well as the tumor itself, Zecyte aids in slowing the progress of cancer and enhances prognosis.

Active Ingredient

• Abiraterone Acetate – 500 mg per tablet

Mechanism of Action

Abiraterone acetate is a selective inhibitor of the enzyme CYP17A1 (17α-hydroxylase/C17, 20-lyase), a critical enzyme in the androgen biosynthesis pathway. Through inhibiting the CYP17A1 enzyme, Zecyte blocks the production of androgens by all sources, such as the adrenal glands, testes, and prostate cancer tissues.

This reduction in circulating and intratumoral androgens deprives prostate cancer cells of the hormones they need to grow and shrink, thereby slowing the rate of growth.

Indications

Zecyte 500mg is indicated for:

• Treatment for metastatic castration-resistant prostate cancer (mCRPC) in patients who’ve received chemotherapy before the diagnosis.
• Utilize in conjunction with prednisone to increase survival rates and stop disease progression.
• Can be utilized in some instances of non-metastatic-resistant prostate cancer, based on medical judgment.

Dosage and Administration

• The dose recommended by Zecyte is 1000 mg a day and taken in the form of two tablets of 500 mg each day on an empty stomach.
• Important: Should be consumed at least 1 hour prior or 2 hours following meals for optimal absorption.
• Zecyte must be used in conjunction with prednisone (5 mg, twice each day) or an equivalent corticosteroid to lessen the possibility of negative side effects due to the excess mineralocorticoid.
• Treatment is continued until progression of the disease or toxicity that is unacceptable develops.
• Regular monitoring by a health specialist is crucial to monitor the response of patients and to manage any consequences.

Pharmacokinetics

• Abiraterone Acetate is a drug that is rapidly converted into active abiraterone following oral administration.
• The peak plasma concentrations can be reached in less than 2 hours when you have an empty stomach.
• It is processed via liver enzymes, specifically CYP3A4 and the SULT2A1.
• The majority of excreted is through the feces.
• Half-life can last for 12 hours. This is in addition to daily doses.

Contraindications

• Hypersensitivity to abiraterone Acetate or any other excipients.
• Patients with severe hepatic impairment (Child-Pugh class C).
• Use in conjunction with powerful CYP3A4 inhibitors or inducers are not recommended without appropriate medical supervision.

Warnings and Precautions

• Hepatotoxicity: Check for liver function before beginning treatment and every month thereafter for the first three months. After that, check the test every three to six months.
• Mineralocorticoid excess: Hypertension can cause hypokalemia, hypertension, and fluid retention. Corticosteroid co-administration is required.
• Cardiac disorders: Take care when using this product for patients who have a history of heart disease. Monitor electrolytes and blood pressure regularly.
• Drug interactions: Be cautious with medications that affect CYP3A4 enzymes.
• Pregnancy: It is not recommended for use by pregnant women.

Side Effects

Common Side Effects:

• Fatigue
• Joint swelling or discomfort
• Edema and fluid retention
• Hot flushes
• Diarrhea or nausea
• High blood pressure (hypertension)

Serious Side Effects:

• Elevated liver enzymes indicating hepatotoxicity
• Hypokalemia (low potassium)
• Cardiac arrhythmias
• Adrenal insufficiency (rare)
• Allergic reactions (rare)

Monitoring

• Baseline and periodic liver function tests (AST, ALT, bilirubin)
• Blood pressure and serum potassium monitors to determine mineralocorticoid excess
• Evaluation of fluid retention in the clinical setting, as well as cardiac signs
• PSA levels are used to determine the response to treatment

Use in Special Populations

• Elderly: Do not require a dose adjustment, but be aware of any side effects.
• Renal impairment: There is no dose adjustment needed in the case of mild or moderate impairment.
• Hepatic impairment: Be cautious in cases of moderate to mild hepatic impairment. Not recommended in extreme impairment.
• Pregnancy and lactation: Inapplicable; not recommended.

Drug Interactions

• The strong CYP3A4 inhibitors (e.g., ketoconazole) could increase levels of abiraterone and increase the risk of toxicity.
• CYP3A4 inducers (e.g., rifampin) could reduce the effectiveness of abiraterone.
• Doses that extend QT intervals must be employed with caution.
• Prednisone and corticosteroids are administered together in order to minimize the adverse effects.

Storage

• Store below 30°C in a dry place protected from moisture.
• Place tablets back in their original packaging in the blister until you need them.
• Be sure to keep away from young children.

Patient Counseling Information

• As directed, take exactly what is prescribed, eating a light meal.
• Don’t eat or drink grapefruit juice for 2 hours prior to and 1 hour following taking Zecyte.
• Report any symptoms of liver problems (jaundice, dark urine, severe fatigue).
• Check your blood pressure frequently and inform us of any swelling or shortness of breath.
• Keep taking corticosteroids according to the instructions given by your physician.
• Avoid abruptly stopping treatment without consulting your physician.

Conclusion

Zecyte 500mg (Abiraterone Acetate) is the cornerstone treatment to treat prostate cancer that is advanced, specifically resistant cases of metastatic castration. Its specific mechanism decreases androgen production, which is crucial to slowing the progression of cancer and enhancing longevity. In combination with corticosteroids as well as proper monitoring, Zecyte offers patients an effective and safe oral treatment that is safe and has no negative side effects.